Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Lattice Biologics Ltd V.LBL.H

Alternate Symbol(s):  LBLTF

Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post... see more

TSXV:LBL.H - Post Discussion

Lattice Biologics Ltd > Great themes in news release - beautiful
View:
Post by PingPong888 on May 11, 2020 9:13am

Great themes in news release - beautiful

It is only logical that AmnioBoost will show promise in treatment of COVID-19 associated lung disease, said Kenneth R. Conger, MD, Medical Director for Lattice Biologics Ltd.
Comment by PingPong888 on May 11, 2020 9:14am
To date, the Company continues to enroll patients in Montana and is in negotiations with contract research organizations (CROs) to facilitate patient recruitment
Comment by PingPong888 on May 11, 2020 9:15am
Additional studies are expected to take place outside the U.S.
Comment by Nomoreshells4me on May 11, 2020 9:16am
Chad Green already said that April 15th " We're optimistic about our positive results, and you know ultimately this won't benefit just Montanans, but people throughout the world," said Green.
Comment by GekkoInvestor19 on May 11, 2020 9:17am
It's nice to look at the glass half full, but the issue has always been recruitment. They've given up on hospital and will now be trying in therapy clinics. Meanwhile competitors are reporting positive results, receiving FDA fast-track and moving onto Stage II and Stage III clinical trials.  I am speculating that it will take them quite some time to acquire the 10 patients and ...more  
Comment by PingPong888 on May 11, 2020 9:21am
Well the problem before was that they never had a specialist on-site to address immediate access to the product and for consultation. The bring of Chad Green has now become a crucial role to be immediately available to patient enrolment. Chad's involvement is a significsng positive effect for me.
Comment by GekkoInvestor19 on May 11, 2020 9:34am
Sounds like were putting a lot of pressure on Chad Green.. It's been several months with them sitting on their hands. Its not as if they're developing a new product, but rather repurposing an existing stem cell treatment. I don't see how bringing on a Respiratory Therapist is going to make a world of difference. Don't get me wrong, I want this stock to shoot for the stars, but I ...more  
Comment by Torontonine on May 11, 2020 9:39am
No pressure . The news release in March made it seem as if they had patients lined up
Comment by DigitalSpurs on May 11, 2020 9:34am
Well, this is a long term hold for me - stem cells will only begin to scratch the surface, especially after its success with COVID19
Comment by PingPong888 on May 11, 2020 9:38am
I agree with digital. Its only been two months since they started. Give them a break. Success comes from 80% effective planning and 20% executing it right the first time.
Comment by Smiles62 on May 11, 2020 9:40am
You should have said that 2 weeks ago instead of your rant about extreme positive news just around the corner for these past 2 weeks!
Comment by PingPong888 on May 11, 2020 9:44am
But it is positive. And I have been saying this.
Comment by Smiles62 on May 11, 2020 9:48am
You are not reading the same news as the market.
Comment by PingPong888 on May 11, 2020 9:49am
Depending on how you see it. Penny flippers and longs have different objectives. This could still sky rocket depending on future news.
Comment by boarman on May 11, 2020 9:58am
Montana is reporting 20 active cases with just 4 hospitalizations. I think if you're long, you're going to be long for a long time.  https://montana.maps.arcgis.com/apps/MapSeries/index.html?appid=7c34f3412536439491adcc2103421d4b
Comment by Torontonine on May 11, 2020 9:59am
They also have access to Denver, NY .
Comment by DigitalSpurs on May 11, 2020 10:05am
Point is this is no longer just COVID - was never just COVID and people went on a COVID trip I agree that Guy needs better communication with Shareholders - we dont need a big up or big down, just some decent updates on what's going on With that said, a lot of loose hands to let shares go now - I'm in no rush and won't take a loss at this price for something that can move quick
Comment by GekkoInvestor19 on May 11, 2020 9:48am
The only positive news are the sources Chad's refers to in his quote. Both from Pluristem and Mesoblast - our direct competition who are showing great success while were holding the bag. The irony.  “As a registered respiratory therapist, I have been treating lung disease and acute respiratory distress syndrome (ARDS) for many years. Stem cells seem to be very well tolerated in treating ...more  
Comment by MaterialWorld on May 11, 2020 9:49am
Markets don't seem to happy. Down to 0.065 cents....MW
Comment by gainwidpatience on May 11, 2020 9:56am
Issue is not with AmnioBoost.. but with CEO and their communication. The way they have managed the communication with shareholders.. reflected their helplessness. Look at the risk factors highlighted in NR.. it was not necessary at all. Same risk factors applies for SZLS.. but look at their NR's, it reflects lot of confidence in getting the work done piece by piece, not thinking how big the ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities